Methicillin-resistant Staphylococcus aureus in surgical patients: identification of high-risk populations for the development of targeted screening programmes.
BACKGROUND
Methicillin-resistant Staphylococcus aureus (MRSA)-related hospital-acquired infection (HAI) in surgical patients is associated with high morbidity, mortality and financial cost. The identification and characterisation of populations of patients who are at high risk of developing MRSA infection or colonisation could inform the design of more effective strategies to prevent HAIs and reduce transmission of MRSA.


METHODS
An analysis of historical discharge data for the whole of 2005 (7145 surgical in-patients) was performed, for all patients admitted to general surgery at the Royal Infirmary of Edinburgh. Analysis specifically focused on MRSA laboratory data and coding data for patient demographics, medical co-morbidities, and progress of in-patient stay.


RESULTS
A total of 134 (1.88%) individual patients with colonisation or infection by MRSA were identified from indicated laboratory testing. Univariate analysis identified a significant association of concurrent MRSA-positive status with patients aged over 60 years (P < 0.01), a duration of inpatient stay > 7 days (P < 0.01), presence of a malignant neoplasm (P < 0.01), circulatory disease (P < 0.01), respiratory disease (P < 0.01), central nervous system disease (P < 0.01), renal failure (P < 0.01), and concurrent admission to ITU/HDU (P < 0.01). Multivariate analysis suggested MRSA colonisation or infection was strongest in those with co-morbid malignancy (P < 0.0001) or admission to ITU/HDU (P < 0.0001).


CONCLUSIONS
This large observational study has identified cancer patients as a UK surgical patient subpopulation which is at significantly higher risk of colonisation by MRSA. These data could inform the development of focused hospital in-patient screening protocols and provide a means to stratify patient risk.
Fraser
Stephanie
S
Department of General Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK. stephanieflofraser@hotmail.com
Brady
Richard R
RR
Graham
Catriona
C
Paterson-Brown
Simon
S
Gibb
Alan P
AP
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003422:Critical Care; D003428:Cross Infection / Q000150:complications / Q000517:prevention & control* / Q000635:transmission; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008403:Mass Screening / Q000458:organization & administration; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D018579:Patient Selection; D013203:Staphylococcal Infections / Q000150:complications / Q000517:prevention & control* / Q000635:transmission; D055815:Young Adult
Clin Infect Dis. 2003 Jan 1;36(1):53-9
12491202
Nihon Geka Gakkai Zasshi. 2002 Dec;103(12):865-8
12599924
Am Fam Physician. 2005 Dec 15;72(12):2474-81
16370403
Infect Control Hosp Epidemiol. 2004 Jun;25(6):461-7
15242192
Chest. 2005 Sep;128(3):1414-22
16162737
J Hosp Infect. 2008 Aug;69(4):315-20
18602183
J Hosp Infect. 2006 Nov;64(3):251-6
16978733
Infect Control Hosp Epidemiol. 2005 Feb;26(2):166-74
15756888
Postgrad Med J. 2002 Jul;78(921):385-92
12151652
Cancer. 2006 Dec 1;107(11):2698-705
17063500
Eur J Vasc Endovasc Surg. 2003 Aug;26(2):145-9
12917828
Surg Today. 1994;24(2):187-8
8054805
J Athl Train. 2006 Jul-Sep;41(3):337-40
17043704
Hepatogastroenterology. 2007 Jul-Aug;54(77):1487-93
17708282
Emerg Infect Dis. 2004 Sep;10(9):1627-34
15498166
Cancer. 2009 Jul 1;115(13 Suppl):3128-34
19544541
Am J Infect Control. 2008 Mar;36(2):118-22
18313513
J Hosp Infect. 2006 May;63 Suppl 1:S1-44
16581155
Am Heart J. 2004 Mar;147(3):536-9
14999206
J Clin Microbiol. 2005 Jan;43(1):132-9
15634961
J Laryngol Otol. 2004 Sep;118(9):694-9
15509366
Infect Control Hosp Epidemiol. 2003 May;24(5):322-6
12785404
BMJ. 2006 Aug 5;333(7562):281
16798756